Table 1

Personal and clinical data of patients (n = 49) and controls (n = 20)
Patients Controls p
No. (%) or median (IQR)* No. (%) or median (IQR)*
Male 40 (81.6) 16 (80) 0.87
Age, y* 49 (43–55) 48.5 (44–54) 0.88
Education, y* 13 (8.5–17) 13 (11.3–14.6) 0.85
Pathological Zung depression scale 5 (10.3)
Transmission risk factor:
Heterosexual 15 (30.6)
Injecting drug users 7 (14.3)
Homosexual 20 (40.8)
Unknown 7 (14.3)
Time from HIV diagnosis, y* 14 (3.5–18.1)
HCV co-infection 9 (18.4)
Past AIDS-defining events 9 (18.4)
Past suboptimal therapy 19 (38.8)
Off Therapy 3 (6.1)
Time from starting last cART regimen, y* 1.6 (1.1 – 3.1)
Time from starting first cART regimen, y* 10.2 (3.1 – 14.6)
CPE rank* 6 (4–7)
HIV-RNA < 50 copies/mL 44 (89.8)
CD4 cell count, cells/μL* 570 (437–734)
CD4 cell count nadir, cells/μL* 211 (115–314)

Abbreviations: No: number; IQR: interquartile range; y: years; cART: combined antiretroviral therapy; CPE: penetration effectiveness score; HCV: hepatitis C virus.

Baldonero et al.

Baldonero et al. BMC Psychology 2013 1:3   doi:10.1186/2050-7283-1-3

Open Data